Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Up until now, the weight loss conversation was a debate between Novo Nordisks GLP-1 semaglutide and Lillys GLP-1/GIP tirzepatide, with research broadly favoring the latter
This is one of the easiest ways to make breakfast happen before your appetite has time to argue with you
GLP-1 Therapy Medical Weight Optimization GLP-1 receptor agonists support weight loss by: Regulating appetite and satiety Slowing gastric emptying Improving insulin sensitivity Supporting metabolic efficiency Our GLP-1 programs include Comprehensive consultation Hormonal and metabolic evaluation Body composition analysis Structured dosing and monitoring Muscle preservation strategy Long-term maintenance planning GLP-1 + GIP (Dual Incretin Therapy) Dual incretin therapy targets both GLP-1 and GIP receptors for enhanced metabolic support
These may include: Nausea, vomiting or diarrhoea (most common early on) Constipation Fatigue Mild increases in heart rate (similar to changes seen with GLP-1 medicines) Side effects were more frequent at higher doses (8 mg and 12 mg), but still rated mild to moderate overall
